| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 6,452 | $8.14 | $52,533.47 | -23.2% | +11.9% | +21.9% | |
| Feb 28, 2022 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 20,598 | $8.14 | $167,713.04 | -50.4% | +11.9% | +21.9% | |
| Feb 9, 2022 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 6,110 | $9.06 | $55,357.82 | -39.4% | -16.7% | +9.2% | |
| Feb 9, 2022 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 6,116 | $9.06 | $55,412.18 | -10.6% | -16.7% | +9.2% | |
| Feb 9, 2022 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 3,583 | $9.06 | $32,463.77 | -9.0% | -16.7% | +9.2% | |
| Feb 9, 2022 | Dethlefs Sven | EVP, North America Commercial | Sale+OE | 4,138 | $9.06 | $37,491.11 | -4.5% | -16.7% | +9.2% | |
| Feb 9, 2022 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 13,135 | $9.06 | $119,009.67 | -39.3% | -16.7% | +9.2% | |
| Aug 10, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sell | 50,860 | $9.95 | $506,021.40 | -55.1% | -7.7% | +10.9% | |
| May 21, 2021 | Drape Eric51 | Executive VP Global Operations | Sell | 40,000 | $11.01 | $440,320.00 | -54.7% | -16.3% | -23.1% | |
| May 11, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 19,066 | $10.22 | $194,829.73 | -17.1% | -2.0% | -28.0% |